Detalles de la búsqueda
1.
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study.
Antimicrob Agents Chemother
; 66(1): e0164321, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34694877
2.
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Lancet
; 393(10167): 143-155, 2019 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420123
3.
Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
J Transl Med
; 17(1): 365, 2019 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711507
4.
Correction for Underwood et al., "Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study".
Antimicrob Agents Chemother
; 67(3): e0032622, 2023 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794938
5.
Dolutegravir + Lamivudine vs. Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Very-Low-Level HIV-1 Replication through 144 Weeks in the GEMINI-1 and GEMINI-2 Studies.
Viruses
; 16(3)2024 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543770
6.
Long-term safety study of fosamprenavir-containing regimens in HIV-1-infected patients.
HIV Clin Trials
; 14(5): 183-91, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24144895
7.
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.
AIDS
; 36(1): 39-48, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34534138
8.
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies.
HIV Res Clin Pract
; 23(1): 9-14, 2021 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34913844
9.
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials.
J Acquir Immune Defic Syndr
; 83(3): 310-318, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31834000
10.
Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis.
J Acquir Immune Defic Syndr
; 84(1): 60-65, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31977595
11.
Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial.
Lancet Infect Dis
; 19(3): 253-264, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30732940
12.
Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies.
J Acquir Immune Defic Syndr
; 94(3): e9-e12, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850985
13.
Treatment-Emergent Mutations and Resistance in HIV-Infected Children Treated with Fosamprenavir-Containing Antiretroviral Regimens.
Open AIDS J
; 9: 38-44, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26157536
14.
Pharmacokinetics, safety and antiviral activity of fosamprenavir/ritonavir-containing regimens in HIV-infected children aged 4 weeks to 2 years-48-week study data.
Pediatr Infect Dis J
; 33(1): 57-62, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23811743
15.
Pharmacokinetics and 48-week safety and antiviral activity of fosamprenavir-containing regimens in HIV-infected 2- to 18-year-old children.
Pediatr Infect Dis J
; 33(1): 50-6, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23811744
16.
A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005.
J Antimicrob Chemother
; 60(3): 587-93, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17597058
17.
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assay.
J Biol Chem
; 280(48): 39709-15, 2005 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-16174771
18.
Characterization of the parB-like yyaA gene of Bacillus subtilis.
J Bacteriol
; 184(4): 1102-11, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11807071
Resultados
1 -
18
de 18
1
Próxima >
>>